Bausch + Lomb, Inc.

Partners Group-PE is an active, long-term manager which follows an integrated approach to make direct, secondary and primary investments in private equity, leveraging its global network to source, analyze and execute a range of investments across asset classes globally.The firm makes direct private equity investments into the equity of selected operating companies, typically together with investee management and taking a board seat. It makes primary investments in newly established private equity partnerships where underlying portfolio companies are not known at the time of investment.It utilizes relative value assessment for different regions and financing stages to select the best private equity segments, seeking to identify and invest with high-quality partners from among its relationships with global private markets managers, advisory board committees and general and limited partners.Partners Group-PE makes secondary investments by acquiring single or portfolios of assets on the secondary market across all asset classes and offering investors liquidity or an exit possibility in a market which is highly liquidity-constrained. It is a value-based secondary investor which understands individual portfolio assets and business models at the fundamental level. It aims to create value by acquiring high quality assets with significant value potential and/or undervalued assets at itts point of inflection and searching for non-competitive acquisitions.

TMT invests in life science and medical technology companies at all stages of development. The firm targets investments in pharmaceutical, medical device, biotechnology and diagnostic sectors and in other areas utilizing medical technology innovation. TMT participates in restructuring transactions including spin-outs, roll ups and recapitalizations.TMP typically invests $5 million to $40 million in one or more rounds of financing, with an average investment of more than $15 million over the life of an investment. Initial investments may be as small as $100,000. The firm prefers to lead the financing round in which they first participate.

Warburg Pincus invests in companies located in the US primarily in North America, Europe and Asia.. The firm focuses on investments in the following sectors: financial services, healthcare, energy, consumer/manufacturing/industrials and technology, media and telecommunications (TMT). They participates in venture capital investments, growth equity investments, spin-outs, LBOs and special situation opportunities. They invest primarily in North America, Europe and Asia.